Nationwide Fund Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,235
Closed -$116K 2024
2017
Q3
$116K Hold
13,235
﹤0.01% 2837
2017
Q2
$110K Buy
13,235
+1,908
+17% +$15.6K ﹤0.01% 2860
2017
Q1
$104K Buy
11,327
+2,739
+32% +$22.4K ﹤0.01% 2831
2016
Q4
$66K Hold
8,588
﹤0.01% 2963
2016
Q3
$65K Hold
8,588
﹤0.01% 3007
2016
Q2
$43K Hold
8,588
﹤0.01% 3095
2016
Q1
$46K Hold
8,588
﹤0.01% 2999
2015
Q4
$62K Hold
8,588
﹤0.01% 2964
2015
Q3
$40K Hold
8,588
﹤0.01% 3056
2015
Q2
$96K Buy
8,588
+3,662
+74% +$36.1K ﹤0.01% 3020
2015
Q1
$36K Hold
4,926
﹤0.01% 3136
2014
Q4
$48K Hold
4,926
﹤0.01% 3026
2014
Q3
$48K Buy
4,926
+140
+3% +$1.84K ﹤0.01% 3104
2014
Q2
$82K Buy
4,786
+1,028
+27% +$14.8K ﹤0.01% 3056
2014
Q1
$64K Buy
3,758
+121
+3% +$1.93K ﹤0.01% 2833
2013
Q4
$53K Buy
+3,637
New +$47.3K ﹤0.01% 3062

Other funds holding VCYT

Nationwide Fund Advisors's VCYT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Veracyte (VCYT) in Q4 2017, closing a stake of 13,235 shares — an estimated $116K sold.

Nationwide Fund Advisors first reported a position in VCYT in Q4 2013 and held it in 16 quarters. The position peaked at $116K in Q3 2017. 79 funds tracked by Wall St. Rank hold VCYT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Veracyte position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 13,235 Veracyte shares in Q4 2017, an estimated $116K.
  • Nationwide Fund Advisors first reported a position in Veracyte in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Veracyte position peaked at $116K in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Veracyte as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.